
Home / Clinics / Sexual Wellness / Men's Sexual Wellness
Most men will not raise this with their primary care physician. They will drive past three clinics to find one that handles it privately and competently. That is the entire business model, and it is why the patient who trusts you in this category tends to stay for years.
Book a Strategy CallPublished estimates put the global erectile dysfunction treatment market between roughly $4.2 billion and $5.7 billion in 2026, with North America holding approximately a third of it. The spread exists because research firms define the category differently. Some count only pharmaceuticals. Others include devices and procedures.
Read those numbers carefully, because they are mostly a drug market. Sildenafil and tadalafil went generic and collapsed in price. A cash-pay clinic is not competing for prescription volume. It competes in procedures, protocols, diagnostics, and ongoing management, which is a different and considerably less crowded lane than the one those figures describe.
The more useful signal is behavioral. This is a category where men consistently pay out of pocket, rarely comparison shop on price, and stay with the first practice that handles the conversation without making it awkward. That combination is unusual, and it is what makes the unit economics work.
Demand is not the constraint here. The constraint is building a practice men actually trust enough to walk into, and then to keep coming back to.
Market figures: Straits Research and Coherent Market Insights, 2026. Estimates vary by market definition. Local demand varies by market.
The service menu below reflects how clinics in this category are commonly structured. It is a description of a business model, not a statement of clinical outcomes, and nothing here is a claim about what any treatment does for any patient. Those determinations belong to your Medical Director and to the evidence.
Device-based protocols delivered in-office, typically sold as a multi-session package rather than a single visit. Device selection and its cleared indications are a Medical Director decision.
Platelet-rich plasma drawn and returned to the same patient in a single visit. Note that several branded protocol names in this space are registered trademarks, so licensing matters if you intend to use them.
The single most common pairing in this category. Many men presenting here are candidates for hormone evaluation, and the two service lines feed each other. See our Men's Health and TRT clinic model.
Prescribing, titration, and follow-up under physician oversight. State rules on prescribing, including via telehealth, vary considerably and shape how this line operates.
Bloodwork, hormone panels, and cardiovascular screening. Structured intake is both clinically appropriate and the foundation of a defensible record.
Frequently added as a secondary service line. Compounded products carry their own 503A and 503B sourcing requirements, covered on our Peptide Therapy page.
Discretion is the product in this category, and remote follow-up supports it. Cross-state prescribing rules apply and vary. See our Telehealth Consulting page.
Every protocol, device selection, and prescribing decision runs through a licensed physician. ACG introduces clients to vetted Medical Directors across all 50 states.
This category attracts aggressive marketing, and aggressive marketing is exactly what draws regulatory attention to it. The Federal Trade Commission polices health claims in advertising, and clinics promising specific results in this space have been a recurring enforcement target for years.
The trap is that most of it is unforced. A device manufacturer hands you marketing materials, you run them as written, and you have now made a claim your clinic is responsible for defending, about a device whose cleared indications may not cover what the copy implies.
The second trap is advertising itself. Meta and Google both restrict this category heavily, and accounts get removed regularly. Operators who plan their entire acquisition strategy around paid social discover the problem after they have signed a lease.
Ask any consultant selling you this clinic model what happens when your ad account gets banned in month two. If they do not have an answer, they have never actually launched one.
Every claim on your site, in your ads, and in your consult scripts is something your clinic must be able to stand behind. ACG builds the messaging framework to be persuasive without crossing into promises you cannot support.
A manufacturer's brochure is a sales document, not a regulatory clearance. ACG helps you ask for the specific clearance and confirm what a device is actually authorized to be marketed for before you build a service line on it.
Because paid platforms restrict this category, search and owned content are the durable channels. ACG builds that infrastructure as part of the engagement rather than leaving you dependent on an ad account that can vanish.
Requirements for the physician relationship, the initial visit, and remote follow-up differ by state. ACG maps this for your specific market before you commit to a model.
Structured intake, informed consent, and clean records are what protect the practice if a claim is ever questioned. This is not paperwork, it is the defense.
Protocols and product selection are formally approved by a licensed physician before first patient. ACG coordinates that relationship across all 50 states.
This is a cash-pay category. Insurance rarely covers it, which removes billing cycles, reimbursement negotiation, and the margin erosion that comes with third-party payers. Patients pay at the point of service.
Protocols here are typically structured as multi-visit programs rather than one-off appointments, and the natural pairing with hormone care means one patient often supports two service lines. Retention in this category is driven by something simple: a man who found a practice that handled this well is not going to start the search over somewhere else.
Cash-Pay
Rarely insurance covered, which means no reimbursement cycles and no payer margin erosion.
Required
ACG coordinates the clinical infrastructure. You own and operate the business.
Launched
Across all 50 states, over 30+ years of combined operational history.
Launch Window
From keys received, market and regulatory conditions permitting.
This category rewards operators who understand the marketing and compliance picture before they sign a lease. The answers below are direct, including the uncomfortable ones.
If something isn't covered here, that's what the consultation is for. No pressure, no pitch.
View All FAQsBook a free 30-minute strategy call. ACG will walk you through the opportunity in your specific market, the compliance picture, the acquisition strategy, and what the process looks like from first conversation to open doors.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time